Shandong Weigao Group increases treasury holdings with H share repurchase

Shandong Weigao Group Medical Polymer Company Limited disclosed a share repurchase on December 15, 2025, involving 120,000 H shares through the Exchange. The shares were repurchased at prices ranging from HK$5.27 to HK$5.29, with an aggregate price paid of HK$633,800. This transaction resulted in a 0.0027% change in the number of issued shares (excluding treasury shares) before the event.

Following the repurchase, the company's treasury shares increased from 30,036,800 to 30,156,800. The total number of issued shares for the company remains at 4,522,332,324. The repurchase was made under a mandate granted on May 27, 2025, which authorized the repurchase of up to 451,560,392 shares.

As of the repurchase date, 23,508,400 shares, representing 5.206% of the issued shares (excluding treasury shares) at the mandate date, have been repurchased. A moratorium period for new share issues or sales of treasury shares following this repurchase is in effect until January 14, 2026.